CA 125 antigen levels in physiological pregnancy at term. Preliminary resultsBO, P; DIPASQUALE, C; ROMAGNOLO, C et al.Journal of foetal medecine. 1987, Vol 7, Num 3-4, pp 89-92, issn 0392-9507Article

Cancer de l'ovaire. Intérêt comparé du CA-125 sérique de l'immunohistochimie et des tests biologiques de l'inflammation = Ovarian cancer: comparative advantages of serum CA-125 and immunohistochemistry of the biologic tests of inflammationGOSSELIN, P; CAZIN, J. L; DEHAUT, J. P et al.Revue française de gynécologie et d'obstétrique. 1987, Vol 82, Num 1, pp 1-5, issn 0035-290XArticle

A new immunoassay using monoclonal antibodies HMFG1 and HMFG2 together with an existing marker CA125 for the serological detection and management of epithelial ovarian cancerDHOKIA, B; CANNEY, P. A; PECTASIDES, D et al.British journal of cancer. 1986, Vol 54, Num 6, pp 891-895, issn 0007-0920Article

Elevated levels of CA-125 in serum of patients suffering from ovarian hyperstimulation syndromeJÄGER, W; DIEDRICH, K; WILDT, L et al.Fertility and sterility. 1987, Vol 48, Num 4, pp 675-678, issn 0015-0282Article

Un nouveau marqueur du cancer de l'ovaire: intérêt diagnostique et thérapeutique = Diagnosis of ovarian cancer: diagnostic and therapeutic interest of a new tumor markerGEORGE, M; BIDART, J. M; BERGMANN, J. F et al.Gynécologie (Paris. 1973). 1987, Vol 38, Num 4, pp 239-242, issn 0301-2204Article

CA-125: use as a tumor marker with mixed mesodermal tumors of the female genital tractPETERS, W. A. III; BAGLEY, C. M; SMITH, M. R et al.Cancer. 1986, Vol 58, Num 12, pp 2625-2627, issn 0008-543XArticle

Levels of CA 125 in patients with recurrent carcinoma of the fallopian tube: two case historiesLOOTSMA-MIKLOSOVA, E; AALDERS, J. G; WILLEMSE, P. H. B et al.European journal of obstetrics, gynecology, and reproductive biology. 1987, Vol 24, Num 3, pp 231-235, issn 0301-2115Article

Evaluation of serum CA 125 levels in the monitoring of ovarian cancerVERGOTE, I. B; BØRMER, O. P; ABELER, V. M et al.American journal of obstetrics and gynecology. 1987, Vol 157, Num 1, pp 88-92, issn 0002-9378Article

Serum CA 125 levels in a group of nonhospitalized women: relevance for the early detection of ovarian cancerZURAWSKI, V. R. JR; BRODERICK, S. F; PICKENS, P et al.Obstetrics and gynecology (New York. 1953). 1987, Vol 69, Num 4, pp 606-611, issn 0029-7844Article

Etude comparative de trois marqueurs dans le cancer de l'ovaire: CA 125, CA 19,9 et ACE = A comparative study of three markers in cancer of the ovary: CA 125, CA 19,9 and CEAVIGNE, E; KREBS, B; KHATER, R et al.Journal de gynécologie obstétrique et biologie de la reproduction. 1986, Vol 15, Num 5, pp 609-613, issn 0368-2315Article

CA 125 antigen in human amniotic fluid and fetal membranesO'BRIEN, T. J; HARDIN, J. W; BANNON, G. A et al.American journal of obstetrics and gynecology. 1986, Vol 155, Num 1, pp 50-55, issn 0002-9378Article

CA 125 : a misleading tumor marker ?SCHRIJVERS, D; VAN DAM, P; VAN OOSTEROM, A et al.International journal of gynaecology and obstetrics. 1996, Vol 55, Num 2, pp 179-180, issn 0020-7292Article

Epidermoid cyst of the spleen with elevated levels of CA125 and carcino-embryonic antigenARDA, Irfan Serdar; TÜZÜN, Meric; HICSÖNMEZ, Akgun et al.European journal of pediatrics. 2005, Vol 164, Num 2, issn 0340-6199, p. 108Article

CA 125 is released by human amnion cells in cultureBARBATI, A; ANCESCHI, M. M; BROCCUCCI, L et al.American journal of obstetrics and gynecology. 1990, Vol 162, Num 1, pp 266-268, issn 0002-9378, 3 p.Article

Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disordersMOORE, Richard G; CRAIG MILLER, Michael; STEINHOFF, Margaret M et al.American journal of obstetrics and gynecology. 2012, Vol 206, Num 4, pp 351-353, issn 0002-9378, 3 p.Article

Mechanism and clinical significance of elevated CA 125 levels in the sera of pregnant womenKOBAYASHI, F; SAGAWA, N; NAKAMURA, K et al.American journal of obstetrics and gynecology. 1989, Vol 160, Num 3, pp 563-566, issn 0002-9378Article

Expression of CEA, CA-125 and SCC antigen by biological fluids associated with pregnancySARANDAKOU, A; KONTORAVDIS, A; KONTOGEORGI, Z et al.European journal of obstetrics, gynecology, and reproductive biology. 1992, Vol 44, Num 3, pp 215-220, issn 0301-2115Article

Factors influencing serum CA 125 levels in normal womenGROVER, S; QUINN, M. A; WEIDEMAN, P et al.Obstetrics and gynecology (New York. 1953). 1992, Vol 79, Num 4, pp 511-514, issn 0029-7844Article

CA125 seric levels in non malignant pathologies = Les taux sériques de CA 125 dans la pathologie non tumoraleRUIBAL, A; ENCABO, G; MARTINEZ-MIRALLES, E et al.Bulletin du cancer. 1984, Vol 71, Num 2, pp 145-148, issn 0007-4551Article

Evaluation of five glycoprotein tumour markers (CEA, CA-50, CA-19-9, CA-125, CA-15-3) for the prognosis of renal-cell carcinomaGRANKVIST, K; LJUNGBERG, B; RASMUSON, T et al.International journal of cancer. 1997, Vol 74, Num 2, pp 233-236, issn 0020-7136Article

Prognostic significance of CA125 in patients with ovarian cancer and secondary debulking surgeryMEIER, W; STIEBER, P; HASHOLZNER, U et al.Anticancer research. 1997, Vol 17, Num 4B, pp 2945-2947, issn 0250-7005Conference Paper

A new tumour marker assay for ovarian cancer on the OPUS immunoassay systemMOLZ, P; TEUTER, C; SCHELP, C et al.Anticancer research. 1997, Vol 17, Num 4B, pp 3051-3053, issn 0250-7005Conference Paper

CA 125 is an indicator for pleural metastases in breast cancerKRAMER, S; JÄGER, W; LANG, N et al.Anticancer research. 1997, Vol 17, Num 4B, pp 2967-2970, issn 0250-7005Conference Paper

CA125 based diagnosis and therapy in recurrent ovarian cancerMEIER, W; BAUMGARTNER, L; STIEBER, P et al.Anticancer research. 1997, Vol 17, Num 4B, pp 3019-3020, issn 0250-7005Conference Paper

Tumor markers in the diagnosis of malignant serous effusionsCASCINU, S; DEL FERRO, E; BARBANTI, I et al.American journal of clinical oncology. 1997, Vol 20, Num 3, pp 247-250, issn 0277-3732Article